Focus
Clinical Trials Investors: Angels and VC Firms
The RaiseHunt database lists 1,360 Clinical Trials investors: 237 angel investors and 1,123 people at 224 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Paris.
Strongest in New York, San Francisco and Paris
- 1,360
- Clinical Trials investors
- 237
- Angel investors
- 1,123
- People at VC/PE firms
- 224
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
1,360 Clinical Trials investors
Showing 561-580
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
MO Merouane Ounadjela Investor at Ardian | San Francisco, United States | Private equity | AIClimate | View profile | |
BH Banyon Harrell Vice President, Mezzanine Capital at Harbert Management | Charleston, United States | Private equityVenture debt | AIClimate | View profile | |
LL Larissa Lin Partner at CD Capital | Shanghai, China | Private equityVenture capital | HardwareHealthcare | View profile | |
DB Drew Burdon Partner at Eqt Life Sciences | United Kingdom | Private equityVenture capital | Healthcare | View profile | |
SB Sam Blumer Athyrium Capital Management, LP at Athyrium Capital Management | New York, United States | Private equityVenture debt | CommerceHealthcare | View profile | |
AE Alex Euler Senior Investment Director at Virginia Venture Partners | Norfolk, United States | Government-backedVenture capital | AIConsumer | View profile | |
AW Alex W. Vice President at Housatonic Partners | San Francisco, United States | Private equity | CommerceConsumer | View profile | |
OP Olivier Personnaz Managing Director at Ardian | Abu Dhabi, United Arab Emirates | Private equity | AIClimate | View profile | |
TF Takeru Furuya Investor at Xontogeny | Cambridge, United States | AcceleratorVenture capital | Healthcare | View profile | |
DG David Grayzel Managing Director at Atlas Venture | Cambridge, United States | Venture capital | CommerceConsumer | View profile | |
CA Carlos Antequera Investor at Novel Capital | Kansas City, United States | Private equityVenture debt | CommerceConsumer | View profile | |
RM Russell Martin Managing Director at Harbert Management | Birmingham, United States | Private equityVenture debt | AIClimate | View profile | |
JE Joyce Erony Managing Partner at Amzak Health Investors | New York City, United States | Private equityVenture capital | FinTechHealthcare | View profile | |
SR Steven Robinette Venture Partner at Atlas Venture | Boston, United States | Venture capital | CommerceConsumer | View profile | |
DC Danielle Cox Investor at Genesys Capital | Erlanger, United States | Corporate VCVenture capital | AIHealthcare | View profile | |
SS Sophie Starck Investor at Avenir | New York, United States | Private equityVenture capital | AICommerce | View profile | |
ZL Zachary Levine Investment Director at Ardian | Guilford, United States | Private equity | AIClimate | View profile | |
AB Alex Ball Investor at Genesys Capital | Washington, United States | Corporate VCVenture capital | AIHealthcare | View profile | |
CT Clay Taylor Harbert Power - Senior Associate, Investments at Harbert Management | Charlotte, United States | Private equityVenture debt | AIClimate | View profile | |
LN Lars Nordal Jensen Chief Investment Officer at BioInnovation Institute (BII) | Copenhagen, Denmark | Accelerator | ClimateFood | View profile |
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal